DATA Waiver Trainings
Providers are required to complete an eight-hour training to qualify for a waiver to prescribe and dispense buprenorphine (Drug Treatment Act of 2000) for 100 or 275 patients. These trainings are certified by the American Society of Addiction Medicine (ASAM) through which physicians are able to obtain the learning requirements necessary to obtain the waiver. These trainings are eight-hour courses (PAs and NPs need an additional 16 hours) that cover treating Opioid Use Disorder using interactive, case-based learning and evidence-based practices. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.
All DATA Waiver Trainings in 2021 will be moved to a webinar format indefinitely to ensure the safety of our participants. Please check here for further COVID-19 updates
Date: October 25, 2021; 8AM-5PM
Presenters: Sheba Sethi, MD, Andy King, MD, and Jonathan Morrow, MD, PhD
Continuing Education Credits (CEUs): Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
An Introduction to Treating Patients with Buprenorphine
As of April 28th, 2021, the Department of Health and Human Services (HHS) announced that the 8-hour X-waiver buprenorphine course is no longer required to prescribe buprenorphine for the treatment of opioid use disorder for less than 30 patients. Clinicians who apply for and receive a DEA X-license may prescribe buprenorphine for OUD for up to 30 patients without taking the official DATA2000 waiver course. The Introduction to Treating Patients with Buprenorphine course is not a required training, however, it is for educational purposes for providers who are interested in prescribing for up to 30 patients.
Date: November 8, 2021; 8AM-12PM
This webinar will offer CMEs
Words: Why I Have a Problem with Them
Date: October 15, 2021; 12-1PM
Presented by: Peer Recovery Project Coordinator, Tim Shewcraft and Communications Specialist, Rachel Bresnahan
Description: An informal discussion on stigma in addiction and the language we use
Polysubstance Discussion: opioid and alcohol use
Date: October 18, 2021; 12-1PM
Presented by: Cara Poland, MD, MEd, FACP, DFASAM, Melissa DeMarse, LPC, and Peer Recovery Project Coordinator, Tim Shewcraft
Description: An informal, interactive dialogue on polysubstance use: alcohol and opioid use